探路者 reported revenue of ¥0.93B for the period ended 2026-06-30, +42.3% year on year. Net income was ¥0.07B, a 7.1% net margin on a 45.3% gross margin. The largest revenue line is 户外服装 at 48% of the total. Free cash flow for the period was ¥-0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.93B | +42.3% |
| Gross profit | ¥0.42B | — |
| Operating income | ¥0.07B | — |
| Net income | ¥0.07B | +578.6% |
| Gross margin | 45.3% | Net margin 7.1% |
| Revenue Q/Q | -12.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| 户外服装 | ¥0.44B | 47.6% |
| 芯片类产品 | ¥0.36B | 38.5% |
| 户外鞋品 | ¥0.09B | 10.0% |
| 户外装备 | ¥0.03B | 3.1% |
| 其他(补充) | ¥0.01B | 0.9% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.51B | 54.7% |
| R&D | ¥0.05B | 5.6% |
| SG&A | ¥0.25B | 27.2% |
| Tax & other | ¥0.00B | 0.2% |
| Item | Amount |
|---|---|
| Total assets | ¥3.35B |
| Total liabilities | ¥1.25B |
| Shareholders' equity | ¥2.10B |
| Equity / assets | 62.7% |
| Operating cash flow | ¥-0.00B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.01B |
| Cash conversion (OCF / net income) | -65% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
莱美药业 ・ 汉威科技 ・ 天海防务 ・ 安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业 ・ 网宿科技 ・ 中元股份 ・ 硅宝科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies